Literature DB >> 18316443

Survival data for canine oral extramedullary plasmacytomas: a retrospective analysis (1996-2006).

Zachary M Wright1, Kenita S Rogers, Joanne Mansell.   

Abstract

In a 10-year period, extramedullary plasmacytomas (EMP) represented 5.2% of all oral tumors found in the dog (16/302). These 16 oral EMP comprised 28.5% of all EMP within the same time period. Eleven dogs died with a median survival time of 474 days. Five dogs remain alive at the time of this writing. Dogs without complete surgical removal of the EMP and no adjuvant therapy had a median survival time of 138 days. Oral EMP have a clinical behavior consistent with EMP arising from other tissues. They have no obvious correlation with multiple myeloma, and complete surgical resection may be curative.

Entities:  

Mesh:

Year:  2008        PMID: 18316443     DOI: 10.5326/0440075

Source DB:  PubMed          Journal:  J Am Anim Hosp Assoc        ISSN: 0587-2871            Impact factor:   1.023


  5 in total

1.  Surgery and radiation therapy for extramedullary plasmacytoma of the penile mucosa in a dog.

Authors:  Jackie M Wypij; Louis-Philippe de Lorimier
Journal:  Can Vet J       Date:  2012-09       Impact factor: 1.008

2.  Tonsillar plasmacytoma in a dog.

Authors:  Yoshimi Iwaki; Colleen Monahan; Rebecca Smedley; David Upchurch; Paulo Vilar-Saavedra
Journal:  Can Vet J       Date:  2018-08       Impact factor: 1.008

3.  Metronomic Chemotherapy for Palliative Treatment of Malignant Oral Tumors in Dogs.

Authors:  Nina Milevoj; Ana Nemec; Nataša Tozon
Journal:  Front Vet Sci       Date:  2022-03-31

4.  Oral Plasmacytoma in a Dog.

Authors:  Indira Pargass; Alissa Bally; Rod Suepaul
Journal:  Vet Sci       Date:  2017-12-14

5.  Canine Cutaneous Plasmacytosis: 21 Cases (2005-2015).

Authors:  B O Boostrom; A S Moore; C J DeRegis; C Robat; K Freeman; D H Thamm
Journal:  J Vet Intern Med       Date:  2017-05-17       Impact factor: 3.333

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.